Singapore has launched its first Guidelines on Management of the Menopause Transition to support healthcare professionals in primary practice caring for women in midlife.
- Study findings: A 2025 study by KK Women’s and Children’s Hospital involving almost 300 primary care doctors and nurses found that nine in 10 were not confident about diagnosing and treating menopausal symptoms.
- Guideline content: The guidelines provide scientifically backed recommendations for management, promote multidisciplinary collaboration, and recognise menopause as a clinical diagnosis.
- Hormone therapy: The guidelines reaffirm that menopause hormone therapy (MHT) is safe and effective for treating symptoms such as hot flushes and menopause-related mood issues, and for preventing osteoporosis. For most women younger than 60, or within 10 years of their last period, the benefits of starting MHT usually outweigh potential risks.
A separate 2025 KKH study of about 1,500 women aged 45 to 65 found that seven in 10 experienced moderate to severe symptoms, and 70 per cent had not sought medical attention.
This summary is based on a report published by The Straits Times.